UNSPSC 51112033: Crizotinib

Crizotinib is an anti-cancer drug acting as an ALK (anaplastic lymphoma kinase) and ROS1 (c-ros oncogene 1) inhibitor, approved for treatment of some non-small cell lung carcinoma (NSCLC).

UNSPSC 51112033 Crizotinib is a Commodity code that nominally covers a single pharmaceutical product — crizotinib, an oral tyrosine kinase inhibitor used in oncology. However, the recent opportunities tagged under this code do not reflect procurement of crizotinib itself. Instead, state and local entities are soliciting generic pharmaceuticals, naloxone, emergency medical supplies, drug standards for forensic analysis, and comprehensive pharmacy benefits network services. The mismatch between the code name and actual buying patterns suggests either broad mis-tagging in state procurement systems or the code's use as a catch-all within pharmaceutical purchasing families. The issuing bodies span county health departments, fire departments, forensic laboratories, and county purchasing offices across Florida, Arizona, Minnesota, Arkansas, and Texas — a mix of health, public safety, and multi-agency cooperative purchasing vehicles. This code shows little activity specifically tied to crizotinib procurement and little decision-relevance for vendors focused on that narrow oncology therapeutic area.

The most recent opportunities under this code reflect generic pharmaceutical manufacturing and distribution rather than specialty oncology drugs. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued an RFP on January 20, 2026 (responses due March 26, 2026) for generic multi-source pharmaceuticals and OTC products through authorized wholesalers, with evaluation weighted 75 percent on price competitiveness and 10 percent on fixed pricing for contract term. Seminole County, Florida's IFB on June 30, 2026 sought 1,900 units of naloxone and 800 safe drug deactivation systems annually for community health initiatives. The City of Tucson Fire Department's RFP (260217) posted June 24, 2026 solicited BLS and ALS pharmaceuticals and supplies alongside vending machines and inventory software, with Section 3 labor, prevailing wage, and Buy America compliance required and evaluation weighted 40 percent price, 35 percent method of approach, and 25 percent qualifications. Pinellas County, Florida's ITQ for certified reference drug standards (April 23, 2026) targeted forensic laboratory analysis with ISO/IEC 17025 accreditation required and Pinellas County SBE preference applied. Geographic concentration in Florida, Arizona, and the multistate cooperative vehicle suggests fragmented demand across local health systems and public safety departments, with no standout repeat buyers visible in the recent block.